Information  X 
Enter a valid email address

C4X DiscoHldg Ord 1P (C4XD)

Date Time Source Announcement
11 Aug 2022 12:43 pm
RNS
Result of Placing to Raise �5.7 million
  7:00 am
RNS
Proposed Placing to Raise Up To �5.7 million
02 Aug 2022 7:00 am
RNS
Business Update
01 Aug 2022 3:09 pm
RNS
Block Listing Interim Review
06 Jul 2022 7:00 am
RNS
C4X Discovery receives Sanofi milestone payment
28 Jun 2022 5:46 pm
RNS
AIM Rule 17 Schedule 2(g) Update
28 Apr 2022 7:00 am
RNS
Half Year Results
19 Apr 2022 7:00 am
RNS
Notice of Results
28 Feb 2022 5:30 pm
RNS
Exercise of Options, Issue of Equity and TVR
03 Feb 2022 7:00 am
RNS
Grant of Options and Directors Dealing
01 Feb 2022 7:00 am
RNS
Block listing Return
  7:00 am
RNS
Bhavna Hunjan Appointed as Chief Business Officer
24 Jan 2022 4:09 pm
RNS
Holding(s) in Company
18 Jan 2022 3:07 pm
RNS
Result of AGM
14 Jan 2022 3:20 pm
RNS
Holdings in Company
21 Dec 2021 7:00 am
RNS
Appointment of Dr Cathy Tralau-Stewart as CSO
15 Dec 2021 7:00 am
RNS
Annual Report and Notice of AGM
13 Dec 2021 6:11 pm
RNS
Total Voting Rights
  7:00 am
RNS
Full Year Results
09 Dec 2021 7:00 am
RNS
Notice of Results
03 Dec 2021 10:34 am
RNS
Clive Dix wins Scrip Lifetime Achievement Award
02 Dec 2021 7:01 am
RNS
Clive Dix awarded Honorary Fellowship
  7:00 am
RNS
Board Change
26 Nov 2021 10:20 am
RNS
Clive Dix wins OBN Special Recognition Award
19 Nov 2021 7:00 am
RNS
Board Change
10 Nov 2021 5:01 pm
RNS
Holding(s) in Company
  4:58 pm
RNS
Holding(s) in Company
08 Nov 2021 4:33 pm
RNS
Holding(s) in Company
03 Aug 2021 5:14 pm
RNS
Total Voting Rights
01 Jul 2021 11:51 am
RNS
Total Voting Rights
27 May 2021 10:04 am
RNS
Exercise of Options
13 May 2021 2:49 pm
RNS
Holding(s) in Company
29 Apr 2021 7:00 am
RNS
Interim Results
22 Apr 2021 4:40 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  11:31 am
RNS
Notice of Results
20 Apr 2021 7:00 am
RNS
Board Appointment
12 Apr 2021 9:30 am
GNW
Up to €414 million Exclusive Worldwide Licensing Agreement with Sanofi for C4XD oral IL-17A inhibitor programme
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Sanofi Agreement
12 Mar 2021 7:00 am
RNS
Holding(s) in Company
11 Mar 2021 9:33 am
RNS
Holding(s) in Company
02 Mar 2021 11:56 am
RNS
Holding(s) in Company
01 Mar 2021 4:26 pm
RNS
Holding(s) in Company
24 Feb 2021 2:03 pm
RNS
Holding(s) in Company
25 Jan 2021 9:37 am
RNS
Holding(s) in Company
19 Jan 2021 2:28 pm
RNS
Result of AGM
23 Dec 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
18 Dec 2020 9:12 am
RNS
Publication of 2020 Annual Report
17 Dec 2020 4:10 pm
RNS
Holding(s) in Company
14 Dec 2020 5:14 pm
RNS
Grant of options and Directors Dealing
10 Dec 2020 7:00 am
RNS
Full Year Results
09 Dec 2020 1:54 pm
RNS
Holding(s) in Company
08 Dec 2020 7:00 am
RNS
Clive Dix named Interim Chair of Vaccine Taskforce
07 Dec 2020 4:05 pm
RNS
C4X Discovery Notice of Results
12 Nov 2020 12:32 pm
RNS
Holding(s) in Company
  11:36 am
RNS
Holding(s) in Company
  9:14 am
RNS
Holdings in Company
11 Nov 2020 6:12 pm
RNS
Holdings in Company
  4:44 pm
RNS
Holding(s) in Company
09 Nov 2020 11:24 am
RNS
Result of General Meeting and Issue of Equity
21 Oct 2020 3:54 pm
RNS
Result of Placing
  7:06 am
RNS
Proposed Placing
10 Sep 2020 10:18 am
RNS
Holding(s) in Company
02 Sep 2020 10:19 am
RNS
Holding(s) in Company
25 Aug 2020 7:00 am
RNS
Business Update
18 Aug 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
29 Jul 2020 2:54 pm
RNS
Cancellation and Regrant of Existing Share Options
21 Jul 2020 2:02 pm
RNS
Holdings in Company
05 Jun 2020 7:00 am
RNS
Clive Dix appointed to the UK Vaccine Taskforce
13 May 2020 3:28 pm
RNS
Holdings in Company
12 May 2020 6:23 pm
RNS
Holding(s) in Company
  2:02 pm
RNS
Holding(s) in Company
07 May 2020 12:36 pm
RNS
Result of Placing
  7:00 am
RNS
Proposed Placing
29 Apr 2020 9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Interim results
28 Apr 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:37 pm
RNS
Price Monitoring Extension
24 Apr 2020 7:00 am
RNS
Notice of Results
30 Mar 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
31 Jan 2020 12:24 pm
RNS
Result of AGM
17 Jan 2020 9:00 am
RNS
Notice of AGM and Posting of 2019 Annual Report
07 Jan 2020 7:00 am
RNS
Full Year Results
12 Dec 2019 11:04 am
RNS
Notice of Full Year Results
09 Dec 2019 1:20 pm
RNS
Altasciences appointed by Indivior
05 Dec 2019 2:24 pm
RNS
Grant of Options
19 Nov 2019 3:38 pm
RNS
Director Dealings
  7:00 am
RNS
Holdings in Company
18 Nov 2019 3:02 pm
RNS
Holdings in Company
  3:00 pm
RNS
Holdings in Company
  2:58 pm
RNS
Holdings in Company
13 Nov 2019 11:21 am
RNS
Result of General Meeting
24 Oct 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  4:02 pm
RNS
Results of Placing
  7:00 am
RNS
Proposed Placing, Subscription and Open Offer
01 Oct 2019 7:00 am
RNS
Business update
27 Sep 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  9:40 am
RNS
Indivior awarded NIH HEAL grant for C4X3256
02 Sep 2019 7:00 am
RNS
C4XD forms Drug Discovery Advisory Network
25 Jun 2019 7:00 am
RNS
C4X Discovery collaboration with PhoreMost
30 Apr 2019 7:00 am
RNS
Interim results
18 Mar 2019 7:00 am
RNS
Notice of Results
06 Mar 2019 11:19 am
RNS
PDMR Shareholdings
15 Jan 2019 10:28 am
RNS
Result of AGM
17 Dec 2018 7:00 am
RNS
C4X Discovery partnership with Horizon Discovery
11 Dec 2018 11:48 am
RNS
2018 Annual Report
06 Dec 2018 7:00 am
RNS
C4X Discovery collaboration with E-Therapeutics
29 Nov 2018 7:00 am
RNS
Discovery partnership with GTN Ltd.
27 Nov 2018 7:00 am
RNS
Discovery partnership with LifeArc
21 Nov 2018 7:00 am
RNS
Full year results for the year ended 31 July 2018
09 Nov 2018 7:00 am
RNS
Notice of Results
22 Oct 2018 7:00 am
RNS
PDMR Shareholding
19 Oct 2018 4:33 pm
RNS
Exercise of Options and Issue of Equity
16 Oct 2018 9:45 am
RNS
Grant of Options and Director Dealing
10 Oct 2018 3:26 pm
RNS
Notification of major holdings
  3:22 pm
RNS
Notification of major holdings
  1:04 pm
RNS
Holdings in Company
  7:00 am
RNS
Holdings in Company
05 Oct 2018 11:11 am
RNS
Result of General Meeting
  10:29 am
RNS
Proposed Placing, Open Offer and Notice of GM
18 Sep 2018 4:53 pm
RNS
Results of Placing
  1:53 pm
RNS
Proposed Placing, Open Offer and Notice of GM
24 Jul 2018 7:00 am
RNS
C4X3256 programme awarded $480k NIDA grant
04 Jul 2018 7:00 am
RNS
Board Changes
01 May 2018 7:00 am
RNS
Collaboration with e-Therapeutics
17 Apr 2018 12:50 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
12 Apr 2018 7:00 am
RNS
Interim results
10 Apr 2018 7:00 am
RNS
Notice of Results
29 Mar 2018 7:00 am
RNS
Indivior deal worth up to $294 Million
18 Jan 2018 2:36 pm
RNS
2017 Annual Report
16 Jan 2018 10:46 am
RNS
Result of AGM
14 Dec 2017 7:00 am
RNS
Full year results for the year ended 31 July 2017
12 Dec 2017 7:00 am
RNS
Notice of Results
13 Nov 2017 7:00 am
RNS
C4XD presents data on Orexin-1 antagonist
20 Sep 2017 10:04 am
RNS
Holding(s) in Company
06 Sep 2017 11:51 am
RNS
PDMR Shareholdings
05 Sep 2017 7:00 am
RNS
Business Update
08 Jun 2017 1:04 pm
RNS
Issue of Equity
05 Jun 2017 10:21 am
RNS
Holding(s) in Company
27 Apr 2017 7:00 am
RNS
Interim results for six months ended 31 Jan 2017
18 Apr 2017 7:00 am
RNS
Notice of Results
06 Apr 2017 8:03 am
RNS
Holding(s) in Company
05 Apr 2017 5:49 pm
RNS
Holding(s) in Company
  12:24 pm
RNS
Holdings in Company
03 Apr 2017 5:22 pm
RNS
Holding(s) in Company
  5:21 pm
RNS
Holding(s) in Company
31 Mar 2017 10:42 am
RNS
Result of General Meeting and Issue of Equity
14 Mar 2017 1:30 pm
RNS
Results of Placing
  7:00 am
RNS
Proposed Placing to raise up to �7.0 million
09 Feb 2017 7:00 am
RNS
Change of Adviser
02 Feb 2017 7:00 am
RNS
GRANT OF OPTIONS AND DIRECTORS DEALING
31 Jan 2017 1:06 pm
RNS
Result of AGM
06 Jan 2017 7:00 am
RNS
Full year results for the year ended 31 July 2016
19 Dec 2016 7:00 am
RNS
Notice of Results
30 Nov 2016 2:25 pm
RNS
Director/PDMR Shareholding
24 Nov 2016 7:00 am
RNS
GRANT OF OPTIONS AND DIRECTORS DEALING
22 Nov 2016 7:00 am
RNS
Board Changes
30 Sep 2016 7:00 am
RNS
Holding(s) in Company
28 Sep 2016 10:41 am
RNS
Holding(s) in Company
  7:00 am
RNS
C4X Enters New Collaboration with Evotec
26 Sep 2016 11:53 am
RNS
Result of General Meeting
06 Sep 2016 7:00 am
RNS
C4X Discovery �5 Million Fundraise
12 Jul 2016 7:00 am
RNS
Acquisition of drug-discovery technologies
04 Jul 2016 7:00 am
RNS
New drug targets identified for development
04 May 2016 7:00 am
RNS
Appointment of Clive Dix as CEO
28 Apr 2016 3:58 pm
RNS
Holding(s) in Company
  3:57 pm
RNS
Holding(s) in Company
26 Apr 2016 7:00 am
RNS
Grant of options
17 Mar 2016 7:00 am
RNS
Interim Results
15 Mar 2016 10:00 am
RNS
Notice of Interim Results
01 Mar 2016 7:00 am
RNS
Acquisition of Genetic Analysis Company
09 Dec 2015 7:00 am
RNS
Director/PDMR Shareholding
08 Dec 2015 2:43 pm
RNS
Result of AGM
19 Nov 2015 7:00 am
RNS
Appointment of Exec Chairman and departure of CEO
06 Nov 2015 7:00 am
RNS
Publication of Annual Report
29 Oct 2015 7:00 am
RNS
Director/PDMR Shareholding
28 Oct 2015 7:00 am
RNS
Preliminary Results
  7:00 am
RNS
Collaboration with the SGC
07 Oct 2015 7:00 am
RNS
Research update: IL-17
23 Sep 2015 7:00 am
RNS
Research update: Breakthrough compounds
03 Sep 2015 7:00 am
RNS
Senior Management and Biology Hires
09 Jun 2015 2:00 pm
RNS
Grant of Options
20 May 2015 7:00 am
RNS
Pre-clinical development of drug candidate
27 Apr 2015 7:00 am
RNS
Interim Results
21 Apr 2015 3:05 pm
RNS
Notice of Results
10 Apr 2015 3:10 pm
RNS
Change of Registered Office
  1:34 pm
RNS
Change of Registered Office
20 Feb 2015 4:45 pm
RNS
Holding(s) in Company
19 Jan 2015 7:00 am
RNS
C4X enters into new research agreement with Evotec
18 Dec 2014 7:00 am
RNS
C4X Discovery renews collaboration with Evotec AG
24 Oct 2014 3:37 pm
RNS
Holding(s) in Company
23 Oct 2014 4:38 pm
RNS
TR-1: Notification of Major Interest in Shares
  3:00 pm
RNS
TR-1: Notification of Major Interest in Shares
  7:00 am
RNS
First Day of Dealings on AIM after ?11m Placing

a d v e r t i s e m e n t